Print

Apricus Biosciences (APRI) CEO to Present at Sachs Annual Biotech in Europe Investor Forum  
9/25/2012 9:28:49 AM

SAN DIEGO, Sept. 25, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Bassam Damaj, Ph.D., President and Chief Executive Officer, will present at the Sachs 2012 Biotech in Europe Investor Forum, being held at the Hilton Zurich Airport Hotel, Switzerland. Apricus Biosciences' presentation will take place on Monday, October 1st at 9:00 a.m. Central European Time.
//-->